Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

Pharma Finals > Chapter 23: Treatment of Cardiac Arrhythmias > Flashcards

Chapter 23: Treatment of Cardiac Arrhythmias Flashcards

1
Q

A disturbance of heart rate or
rhythm caused by an abnormal rate of electrical impulse
generation by the SA node or by the abnormal conduction
of impulses

A

Arrhythmia (Dysrhythmia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Arrhythmias are classified by
1. Origin:
2. Pattern
3. Speed/Rate

A

Origin: Ventricular, Supraventricular (Atrial)

Pattern: Fibrillation or flutter

Speed/Rate: Tachycardia or bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Etiology of Arrhythmias

A

● Congenital
● Hypertension
● previous MI
● Heart failure
● Valvular heart disease
● irritability after surgery
● degeneration of conductive
tissue (sick sinus syndrome)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Arrhythmia Risk Factors

A

● Diabetes
● Obstructive sleep apnea
● smoking
● alcohol
● increased pulse pressure
● family history
● LVH
● increased BMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Pathogenesis & Clinical Manifestations of Arrhythmias

A

● can be changes in either the heart’s rate
or its cardiac conduction pattern
● some arrhythmias will affect rate only, some rhythm
only, some affect both rate and rhythm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Normal Heart Rate

A

60-100 beats/min
(an arrhythmia is considered to be any significant deviation
from the normal range)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q
  • More than 110 beats/min;
  • Increased sympathetic stimulation (fear, pain, emotional stress, exertion, exercise, caffeine, nicotine, amphetamines), exercise (transient physiologic state)
A

Tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q
  • Less than 50 beat/min
    ■ normal in well trained athletes, in individuals taking beta blockers, pts with TBI or brain tumors, and increased vagal stimulation to the pacemaker of the heart
    ■ Organic disease of the sinus node, heart disease
    ■ Symptoms: fatigue, dyspnea, syncope, dizziness, angina, diaphoresis
    ■ Medical intervention is not usually necessary unless symptoms interfere with
    function, low cardiac output, drug or angina induced.
    ■ Atropine or Mechanical pacemaker can be used to reestablish normal rhythm
A

Bradycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q
  • Detected when patients become symptomatic or during monitoring for
    another cardiac condition.
  • Symptoms: Asymptomatic, syncope or near syncope, dizziness, chest
    pain, dyspnea, palpitations
  • sudden cardiac death
  • Altered cardiac output -> impaired perfusion of the brain or
    myocardium
A

Arrhythmias as variations from the normal rhythm of the heart

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

● Irregular rhythm that may be a normal variation in athletes,
children, and older people or may be caused by and alteration in vagal stimulation.
● May be respiratory or
nonrespiratory, associated with
infection, drug toxicity, or fever
● Treatment for the respiratory type
of sinus arrhythmia is not necessary; all others sinus arrhythmias are treated by providing intervention for the
underlying cause

A

Sinus Arrhythmia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

● Most common type of supraventricular tachycardia (SVT) or chronic arrhythmia
● SVT is also called paroxysmal SVT or paroxysmal atrial tachycardia
● Irregularly irregular
● No P waves
● Absence of isoelectric baseline

A

Atrial Fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

SVT is also called

A

Paroxysmal SVT or paroxysmal atrial tachycardia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Self-terminating episode <7 days

A

Paroxysmal AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

not self-terminating, >7 days

A

Persistent AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

> 1 year

A

Long-standing Persistent AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

> 1 year, wherein rhythm control interventions are not pursued or are
unsuccessful

A

Permanent (accepted) AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Irregular contraction of the atrial myocardium

A

Quivering

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Atrial Fibrillation

A

● blood remains in the atria after they contract and the ventricles do not fill properly
● as the heart rate increases, there is less time for passive ventricular filling from
the atria
● blood flow from the heart diminshes, creating a drop in oxygen levels
● Sx: SOB, palpitations, fatigue, fainting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Rheumatic heart disease, dilated cardiomyopathy, atrial septal defect, hypertension, mitral valve prolapse, recurrent cardiac surgery, after MI,
hypertrophic cardiomyopathy, hyperthyroidism, medications, diabetes, obesity, pneumonia, alcohol intoxication/withdrawal

A

Secondary AF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

People with AF are prone to:

A

blood clots

(because blood components remain in the atria and aggregate and attract other
components, triggering clot formation.)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

AF can result in:

A

HF, cardiac ischemia, and
arterial emboli that can result in ischemic
stroke

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q
  • An electrical phenomenon that results in INVOLUNTARY, UNCOORDINATED MUSCULAR CONTRACTIONS of the
    VENTRICULAR MUSCLE
  • A FREQUENT CAUSE OF CARDIAC ARREST
  • Treatment is directed toward DEPOLARIZING the muscle, thus ending the irregular contraction and allowing the heart to resume normal regular contractions.
A

Ventricular Fibrillation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

Interruption in the passage of impulses through the heart’s electrical system. This may occur because the SA node misfires or the impulses it generated are not properly transmitted through the heart’s conduction system.

A

Heart Block

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

Heart block causes, symptoms, and treatment:

A

● Causes: coronary artery disease, hypertension, myocarditis, acute MI
overdose of cardiac meds
● Symptoms: fatigue, dizziness, fainting

● can affect any people at any age, but primarily affects older people

● Treatment: mild cases do not require treatment, Medications, pacemakers

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

● Or brady-tachy syndrome
● complex cardiac arrhythmia and conduction disturbance
○ bradycardia alone, bradycardia alternating with tachycardia, or bradycardia with atrioventricular
block (AV) block
● associated with advanced age, CAD, HF, or drug therapy
● Degeneration of conductive tissue necessary to maintain normal heart rhythm
● symptoms: light-headedness, dizziness, near or true syncope

A

Sick Sinus Syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Rapid depolarization; no influx

A

PHASE 0

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Brief period of repolarization: K channels open, K
leaves the cell

A

PHASE 1

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Plateau phase: Ca channels open, slow,
prolonged, influx of Ca, K still leaves the cell. No
net change in cell charge

A

PHASE 2

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Repolarization is complete: closing of Ca+
channels, stops Ca influx. Unopposed exit of K ions

A

PHASE 3

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

Slow spontaneous depolarization: membrane ions
allow continuous leak of sodium ions into the cell, gradual decrease in K exit from the cell;
intracellular Ca release from SR; net change is
accumulation of positive cell charge, reaching
threshold and phase 0 again

A

PHASE 4

31
Q

Normal conduction of Cardiac Action Potential

A

SA Node > Atrial Conduction Pathways > AV Node > Bundle of His > Right and Left bundle branches > Purkinje Fibers

32
Q

Mechanisms of Cardiac Arrhythmias

A

Any factor can disrupt the normal cardiac excitation process leading to
arrhythmic contractions:
○ metabolic and electrolyte imbalances
○ abnormal autonomic influence
○ toxicity to other drugs
○ psychological distress
○ myocardial ischemia
○ infarction
○ heart failure, hypertension
○ genetic factors
● Abnormal impulse generation
● Abnormal impulse conduction
● Simultaneous abnormalities of impulse generation

33
Q

Type of arrhythmia with:

Fibrillatory waves
● MC sustained cardiac arrhythmia in older
adults
● Atrial rate >300-350 bpm; ventricular rate
varies
● Rhythm: irregularly irregular
● P waves: no discernable P wave
● QRS: normal

A

Atrial Fibrillation

34
Q

Type of arrhythmia with:

Sawtooth pattern
● Macroreentrant atrial tachycardia
● Organized reentry creates organized but
rapid atriala activity
● Rate: atrial rate is 250-350bpm;
ventricular rate varies
● Rhythm: variable
● P-waves: saw-tooth appearance
● QRS: usually normal

A

Atrial Flutter

35
Q

Atrioventricular Junctional Arrhythmias

A

Junctional Rhythm: 40-55 bpm
Junctional Tachycardia: 100-200 bpm

36
Q

Pacemaker: AV junction with ventricular rate of 40-60bpm
P wave may appear, after or buried within QRS complex
Rhythm: regular
QRS: narrow

A

Junctional (Atrioventricular) Rhythm

37
Q

Variable Conduction Disturbances

A
  • Atrioventricular block
  • Bundle branch block
  • Fascicular block
38
Q

Ventricular Arrhythmias

A

Premature ventricular contractions - variable

Ventricular tachycardia - 140-200 bpm

Ventricular fibrillation - Irregular; totally uncoordinated rhythm

39
Q
A
40
Q

-prematurely occurring QRS complex which is wide and bizarre-looking
- no preceding p-wave
-T wave is opposite in deflection compared to the bizarre QRS complex

A

Premature ventricular complex

41
Q

-continuous irregular activation with no discrete QRS complexes
- chaotic or fine undulations
-no Pwaves
- no effective cardiac output (CO)

A

Ventricular Fibrillation

42
Q

● Bind to membrane sodium channels
● Class I drugs normalize the rate of sodium entry into the cardiac tissues and thereby help control cardiac
excitation and conduction
● Sodium influx plays an important role during phase 0 of cardiac action potential generation
● Inhibition of Sodium channels decrease membrane excitability
● Class I drugs stabilize the cardiac cell membrane and normalize the rate of cardiac cell firing.

A

Class I - Sodium Channel Blockers

43
Q

● Produce a MODERATE slowing of phase 0 depolarization and moderate slowing of action potential
propagation through the myocardium
● Prolong repolarization of the cardiac cell, thus lengthening the interval before a second action potential
can occur - increases the effective refractory period

A

Class IA

44
Q

Slows the upstroke, slows conduction, prolongs QRS by blockade of sodium channels

A

Quinidine (Class IA)

45
Q

○ Same as quinidine; also prolongs the action potential duration (a Class 3 action).
○ Ganglion blocking properties: reduces peripheral vasoconstriction
○ AE: hypotension
○ Uses: Ventricular tachyarrhythmis

A

Procainamide (Class IA)

46
Q

○ Effects similar to quinidine
○ Negative inotropic effects (depresses contractility)
○ Uses: atrial flutter, atrial fibrillation, hypertrophic cardiomyopathy
○ AE: anticholinergic actions - precipitation of glaucoma, constipation, dry mouth, urinary retention, Torsades de pointes

A

Disopyramide (Class IA)

47
Q

● MINIMAL ability to slow phase 0 depolarization; MINIMAL slowing of cardiac conduction
● Shorten cardiac repolarization - Effective refractory period is decreased

A

Class IB

48
Q

○ Lidocaine is a local anesthetic; useful in the acute IV therapy of ventricular arrhythmias
○ Blocks both open and inactivated cardiac Na channels
○ Decreases automaticity by reducing the slope of phase 4 and altering the threshold for excitability
○ AE: seizures in large IV rapid doses; tremor, dysarthria, altered level of consciousness in
maintenance therapy
■ Nystagmus is an early sign of lidocaine toxicity

A

Lidocaine (Class IB)

49
Q

○ Analogue of lidocaine that has been modified to reduce first-pass hepatic metabolism
○ AE: dose related: nausea, tremor; minimized by taking the drug with food

A

Mexiletine (Class IB)

50
Q

Indications: ventricular tachycardia, premature ventricular contractions (PVCs)

Tocainide

A

Class IB

51
Q

● Marked decrease in the rate of phase 0 depolarization
● Marked slowing of cardiac conduction; little effect on repolarization

A

Class IC

52
Q

○ Blocks Na channel; blocks K channels
○ AE: dose-related blurred vision; exacerbation of CHF, provocation or exacerbation of potentially lethal arrhythmias, heart block

A

Flecainide (Class IC)

53
Q

○ Blocks Na channel; blocks K channels
○ B adrenergic blockade
○ Major effect: to slow conduction in fast-response tissues
○ Prolongs PR and QRS duration
○ Indication: maintains sinus rhythm in patients c SVTs including Atrial Fibrillation; ventricular
arrhythmias
○ AE: acceleration of ventricular response in atrial flutter
○ Increased severity of reentrant vtach, exacerbates HF; b adrenergic: sinus bradycardia and
bronchospasm

A

Propafenone (Class IC)

54
Q

Indications: ventricular tachycardia and PVCs

A

Class IC

55
Q

● Mainstay in arrhythmia treatment

● Beta blockers decrease excitatory effects of the SNS and related catecholamines on the heart (NE, Epi)
○ Decrease cardiac automaticity
○ Prolongs the effective refractory period - slowing the heart rate
○ Controls the function of the AV node

A

Class II - Beta Blockers

56
Q

Class II Indications

A

Atrial tachycardia, ventricular tachycardia

57
Q

Class II (Beta Blockers) example

A

Acetabulol, atenolol, emsolol, metoprolol, nadolol, propranolol, sotalol, timolol

AE: for nonselective beta blockers, bronchoconstriction in patients with BA and COPD, excessive slowing
of cardiac conduction

58
Q

● Drugs that prolong ERP by prolonging the Action Potential (AP)
● These drugs prolong the action potential by blocking the potassium channels or by enhancing inward
current through sodium channels

A

Class III: Drugs that Prolong Repolarization

59
Q

Class III Effects and Indications

A

○ Limits potassium efflux during phase 2 and 3 of the AP
○ lengthens time interval before a subsequent AP can be initiated

Indication: ventricular tachycardia, ventricular fibrillation, SVTs, post-op Afib

60
Q

○ Class I,II,III IV effect
○ Indication: supraventricular arrhythmias, atrial fibrillation
○ AE: pulmonary toxicity, thyroid problems, liver damage, bradycardia, heart block in preexisting
sinus or AV node dse.

A

Amiodarone (Class III)

61
Q

○ Class III effect; 100% bioavailable
○ Indications: maintenance of sinus rhythm in atrial fibrillation

A

Dofetilide (Class III)

62
Q

○ analog of amiodarone that lacks iodine atoms
○ for treatment of atrial flutter and fibrillation
○ no pulmonary toxicity and thyroid dysfunction in short-term studies;

A

Dronedarone (Class III)

63
Q

Ibutilide

A

Class III

64
Q

Class III Adverse Effects

A

proarrhythmic: torsades de pointes

65
Q

● Selective ability to block calcium entry into myocardial and vascular smooth-muscle cells
● Inhibit calcium influx by binding to specific channels during phase 2 -> alter the excitability and conduction of cardiac tissues
Effects:
○ Decrease rate of discharge of SA node
○ Inhibit conduction velocity through the AV node

A

Class IV: Calcium Channel Blockers

66
Q

Class IV indications

A

SVT, Afib

67
Q

○ Used to treat CHF, A fib, paroxysmal AV nodal reentrant tachycardia

A

Digitalis glycosides

67
Q

Class IV Drugs; both normalize heart rate by reducing calcium effects on the SA and AV nodes

A

Verapamil, Diltiazem

68
Q

Class IV Adverse Effects

A

bradycardia (<50bpm), peripheral vasodilation -> headache and dizziness

69
Q

○ Ventricular arrhythmias (ie. Torsades de pointes)

A

Magnesium

70
Q

○ Used to terminate severe arrhythmias (ie. reentrant supraventricular tachycardia)
○ Binds to adenosine receptors and affects heart rate by decreasing calcium entry into myocardial
tissues

A

Adenosine

71
Q

○ Help control atrial and ventricular arrhythmias with minimal proarrhthmic effect

A

Ranolazine

72
Q

Nonpharmacologic treatment

A

● Implants:
○ Pacemakers
○ Cadiovert defibrillators
● Surgical:
○ Electrode catheter ablation

Pharma Finals (4 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions